Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.4 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.4 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.4 |
mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.035 | 0.4 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |